Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Eucure (Beijing) Biopharma Co., Ltd
Scientific Title
A First-In-Human, Multicenter, Open-Label, Phase I Dose Escalation Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of YH004 As A Single Agent And Combination With Toripalimab In Subjects With Advanced Solid Tumors And Relapsed Or Refractory Non-Hodgkin Lymphoma